BioMark has recently completed a very encouraging metabolome study that has implication for biomarker signature related to cancer diagnosis. The discovery is being patented.
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
BioMark’s Liquid Biopsy Platform Selected for Holistic German Lung Cancer Screening Trial Extensive Validation of
Form 7 Monthly Progress Report September 2025 Name of Listed Issuer: Trading Symbol: Number of
BioMark Secures Key Patents in Asia’s Largest Markets for Early Lung Cancer Liquid Biopsy Pioneering
Form 7 Monthly Progress Report September 2025 Name of Listed Issuer: Trading Symbol: Number of
BioMark Diagnostics Establishes African Market Presence Through Strategic Tunisia Healthcare Partnership Proof-of-Concept Trial Opens Door
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2